Dr. Reddy's Laboratories Limited (RDY)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 69.61 |
| Open | 69.60 |
| Bid | 28.89 x 800 |
| Ask | 70.48 x 1300 |
| Day's Range | 69.12 - 69.85 |
| 52 Week Range | 54.03 - 77.72 |
| Volume | |
| Avg. Volume | 208,324 |
| Market Cap | 11.726B |
| Beta (5Y Monthly) | 0.34 |
| PE Ratio (TTM) | 17.30 |
| EPS (TTM) | 4.02 |
| Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 0.49 (0.70%) |
| Ex-Dividend Date | Jul 07, 2023 |
| 1y Target Est | 80.89 |
Business WireAlvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
HYDERABAD, India & REYKJAVIK, Iceland, May 21, 2024--Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva®.
ZacksWhy Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Insider MonkeyDr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript May 7, 2024 Dr. Reddy’s Laboratories Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, good day, and welcome to the Q4 and Full-Year FY2024 Earnings Conference […]
© 2024 Yahoo. All rights reserved.